project id: TCGA-SKCM; case submitter id: TCGA-EE-A2GR; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 9.4; age at index: 78; days to birth: -28510; days to death: 1301; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1931; age at diagnosis: 28510; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T4; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 435.0; icd 10 code: C49.1; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of upper limb and shoulder; synchronous malignancy: No; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 622; days to sample procurement: 0; initial weight: 160.0; portion submitter id: TCGA-EE-A2GR-06A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 1.0; percent necrosis: 1.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 19.0; percent tumor cells: 75.0; percent tumor nuclei: 75.0;